Coexisting Psoriasis and Anti-P200 Pemphigoid: A Case Report
Main Article Content
Keywords
autoimmune bullous disease, psoriasis, pemphigoid, case report
Abstract
Psoriasis and autoimmune bullous diseases have been shown to coexist in certain patients. Notably, anti-p200 pemphigoid has been associated with psoriasis. We present a case of a patient who presented with psoriasis and was also found to have anti-p200 pemphigoid. This case highlights the importance of recognizing this association, which may aid in diagnosis but also poses an interesting challenge in co-managing these two entities.
References
2. Dainichi T, Kabashima K. Interaction of Psoriasis and Bullous Diseases. Front Med (Lausanne). 2018 Aug 8;5:222. doi: 10.3389/fmed.2018.00222
3. Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, Zhang M, Tang CH. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci. 2011 Jul;63(1):40-6. doi: 10.1016/j.jdermsci.2011.03.002
4. Chen KR, Shimizu S, Miyakawa S, Ishiko A, Shimizu H, Hashimoto T. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen. Br J Dermatol. 1996 Feb;134(2):340-6.
5. Xie YH, Wang SH, Li SZ, Zuo YG. Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review. Front Immunol. 2022 Mar 4;13:839094. doi: 10.3389/fimmu.2022.839094
6. Kridin K, Ahmed AR. Anti-p200 Pemphigoid: A Systematic Review. Front Immunol. 2019 Oct 22;10:2466. doi: 10.3389/fimmu.2019.02466
7. Goletz S, Hashimoto T, Zillikens D, Schmidt E. Anti-p200 pemphigoid. J Am Acad Dermatol. 2014 Jul;71(1):185-91. doi: 10.1016/j.jaad.2014.02.036
8. Laufer Britva R, Amber KT, Cohen AD, Kridin K. Treatment and clinical outcomes in anti-p200 pemphigoid: a systematic review. J Eur Acad Dermatol Venereol. 2020 Mar;34(3):465-472. doi: 10.1111/jdv.15961
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.